market

Bausch gets Chinese approval for Thermage FLX and TR-4 return pad


Bausch Health US headquarters in Bridgewater, NJ, USA.

JHVEPhoto/iStock Editorial via Getty Images

Soltera, a unit of Bausch Health Companies (NYSE:BHC), said that Chinese regulators have approved its Thermage FLX and TR-4 return pad for the treatment of wrinkles.

The Thermage system uses radiofrequency technology to help tighten skin and improve its texture. Thermage



READ SOURCE

Readers Also Like:  RUTH SUNDERLAND: Greed of mortgage lenders cashing in on families' misery

This website uses cookies. By continuing to use this site, you accept our use of cookies.